Abby Pharma (U.K) LLP

	Registered number:
	OC413389

	Abby Pharma (U.K) LLP
	Unaudited Accounts
	for the Year Ended
	31 August 2025

		2025 £		2024 £
Current Assets
Debtors	2,169,831		2,049,866
Cash at bank and in hand	1,270,541		996,526
	3,440,372		3,046,392

Creditors falling due within one year	(1,053,506)		(1,395,619)

Net Current Assets / (Liabilities)		2,386,866		1,650,773

Creditors falling due after more than one year		(0)		(3,266)

Net Assets Attributable to Members		2,386,866		1,647,507

Loans and other debts due to members within one year
Represented by:
Members' capital classified as a liability	3	2,278,488	1,539,129
		2,278,488	1,539,129

Members' other interests
.
Members' capital classified as a equity	3	108,378	108,378
		2,386,866	1,647,507

Total members' interests
.
Loans and other debts due to members	2,278,488	1,539,129
Members' other interests	108,378	108,378
	2,386,866	1,647,507

These accounts have been prepared and delivered in accordance with the provisions applicable to LLPs subject to the small LLPs regime.

The members have not delivered a copy of the LLP's Profit and Loss account as permitted by s444(5A) of the Companies Act 2006 (as applied to LLPs).

The members acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 (as applied to LLPs) with respect to accounting records and the preparation of accounts.

For the year ended 31 August 2025 the LLP was entitled to exemption under section 477 of the Companies Act 2006 (as applied to LLPs) relating to small LLPs.

The financial statements were approved by the members and signed on their behalf by:

.........................................................

Approved by members on 2 June 2026

Meniland Group Ltd

Designated Member

Abby Pharma (U.K) LLP

Registered number: OC413389 (England and Wales)

1.	Accounting Policies
	Basis of preparation These financial statements have been prepared under the historic cost convention in accordance with the accounting policies set out below and with section 1A of FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland, the Companies Act 2006 and the Statement of Recommended Practice "Accounting by Limited Liability Partnerships". These financial statements reflect the results of the LLP for the year ended 31 August 2025.

Accounting Policies

Basis of preparation

These financial statements have been prepared under the historic cost convention in accordance with the accounting policies set out below and with section 1A of FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland, the Companies Act 2006 and the Statement of Recommended Practice "Accounting by Limited Liability Partnerships".

These financial statements reflect the results of the LLP for the year ended 31 August 2025.

	Turnover
	Turnover represents amounts due in respect of trade plus indirect taxes and fees during they year

	Tax provisions
	Taxation on the profits of the LLP is solely the liability of individual members. Therefore, neither income tax nor deferred tax arising in respect of the LLP's profit is included in these financial statements.

2.	Employees
		2025		2024
	Average number of employees during the period	0		0

3. Members' Interests
	Members capital classed as equity	Other reserve	Total 2025	Total 2024
	£	£	£	£
Brought Forward	108,378	1,718,444	1,647,507	2,025,243
Profit (loss) for period available for discretionary division among members	-	739,359	739,359	(377,736)
Members' interest after profit (loss) for period	108,378	2,457,803	2,386,866	1,647,507
Other divisions of profits (losses)	-	-	-	-
Balance carried forward	108,378	2,457,803	2,386,866	1,647,507